首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1757559

全球馬獸醫護理市場

Equine Veterinary Therapeutics

出版日期: 2025年06月27日 | 出版商:

Global Industry Analysts, Inc. | 英文 378 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球馬獸醫護理市場規模將達到 17 億美元

全球馬獸醫治療市場規模預計在2024年為12億美元，預計到2030年將達到17億美元，在2024-2030年的分析期內，複合年成長率為6.4%。抗發炎藥物是本報告分析的細分市場之一，預計其複合年成長率為7.9%，到分析期結束時將達到8.441億美元。感染疾病物細分市場在分析期間的複合年成長率預計為4.2%。

美國市場規模估計為 3.143 億美元，中國市場預計複合年成長率為 10.4%

預計到2024年，美國馬獸醫治療市場規模將達3.143億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到3.502億美元，在2024-2030年的分析期間內，複合年成長率為10.4%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個國家的複合年成長率分別為3.1%和6.3%。在歐洲，預計德國市場的複合年成長率為4.2%。

全球馬獸醫護理市場—主要趨勢和促進因素摘要

臨床介入的進步將如何改變馬匹醫療保健？

近年來，在藥理學、再生醫學和精準診斷領域創新的推動下，馬獸醫護理領域取得了長足進展。以疼痛管理、抗寄生蟲藥物和抗生素為中心的傳統治療方案正迅速被旨在從細胞層面治療慢性疾病的生物和分子療法所補充，在某些情況下甚至被取代。特別是，骨關節炎、肌腱炎和舟骨病等肌肉骨骼疾病的治療已從依賴皮質類固醇和非類固醇消炎劑轉向依賴富血小板血漿 (PRP)、自體調理血清 (ACS) 和幹細胞療法等生物製藥。

運動馬和表演馬中常見的呼吸系統疾病也越來越受到重視。目前，新型支氣管擴張劑、黏液溶解劑和免疫調節劑正被開發用於更精準地治療馬氣喘和復發性氣道阻塞 (RAO)，並減少副作用。此外，荷爾蒙和代謝失衡，尤其是馬METABOLIC INC.症候群 (EMS) 和腦下垂體隔膜功能障礙 (PPID)，正在採用包含長效促效劑、代謝調節劑和胰島素增敏劑的先進配方進行治療。這些進展正在提高飼主護理人員的依從性，並實現更持續的疾病管理。

再生醫學和基因療法在馬的恢復和表現中扮演什麼角色？

再生醫學與馬匹治療的結合正在改變傷害恢復的軌跡，尤其對於注重持續表現的精英馬術運動員而言。幹細胞療法，尤其是利用骨髓或脂肪組織來源的間質幹細胞(MSC)，在肌腱損傷、軟骨損傷和關節退化的治療中正日益成為常規療法。這些細胞具有免疫調節特性和組織特異性再生能力，可顯著降低高性能馬匹的再次損傷率。獸醫師們也嘗試使用外泌體（即富含生長因子的細胞外囊泡）來增強細胞訊號傳導，促進損傷部位的癒合。

基因療法也是一項新興領域，但目前仍處於研究和測試階段，無法廣泛應用於馬匹。實驗方法包括使用病毒載體將抗發炎細胞激素和軟骨保護基因直接遞送至受影響的關節和組織。儘管監管和成本障礙仍然存在，但其長效甚至永久性治療效果的潛力有可能重新定義馬醫學的慢性病照護。衝擊波療法、雷射療法和脈衝電磁場療法等補充技術也正與再生療法結合使用，以改善療效、縮短癒合時間並支持復健計畫。這些先進的生物療法與熱感成像和超音波等改進的診斷工具相結合，可以實現更早的干涉和更精確的治療監測。

治療通訊協定如何發展以滿足特定的市場和最終用途需求？

全球馬獸醫治療市場需求結構差異巨大，區域需求、馬術學科和經濟因素都會影響治療方法的發展和應用。在北美和歐洲，賽馬、場地障礙賽和馬場馬術佔據著競爭的主導地位，治療通訊協定強調合規性、反興奮劑標準和積極的健康策略。這些地區的獸醫診所配備了影像室、內視鏡和手術室，能夠進行關節鏡手術、整形外科固定和先進的傷口處理等複雜的干涉措施。這些市場越來越重視預防性治療以及對關節健康、代謝狀態和免疫標記的縱向監測。

相反，巴西、印度和中東等新興馬匹市場正在尋求可用於賽場的經濟高效的治療方法。絞痛、寄生蟲感染疾病和傷口感染疾病等常見疾病正在推動口服驅蟲藥、抗菌粉劑和電解質治療的需求。然而，收入水準的提高和國際比賽參與度的提高也推動了人們對提高運動表現的藥物、注射關節補充劑和賽前調理劑的興趣。此外，治療方法也不斷發展，以滿足非競技環境中馬匹的需求，例如治療馬和休閒馬，在這些環境中，行為健康和慢性疼痛管理是關鍵問題。行為藥物，尤其是抗焦慮藥物和天然鎮靜劑，在使用馬匹進行馬匹輔助治療和康復的機構中越來越受歡迎。

哪些因素推動了全球馬獸醫治療市場的成長？

馬獸醫護理市場的成長受到多種因素的推動，這些因素反映了馬匹護理的醫療化、馬術運動的專業化以及馬主和馴馬師對馬匹健康狀況日益成長的期望。最突出的成長要素之一是馬匹在競技運動、治療、休閒和禮儀用途等各個領域的應用日益廣泛。一匹賽馬的經濟價值通常高達數十萬至數百萬美元，因此有必要投資先進的診斷技術、預防醫學和新型療法，以延長馬匹的運動壽命並降低災難性損傷的風險。

另一個強勁的成長催化劑是加強監管和臨床基礎設施建設，以支持循證獸醫實踐。獸醫協會、製藥公司和馬術監管機構正在攜手合作，以標準化治療通訊協定，改善藥品核准途徑，並促進治療研發創新。獸醫對人類藥物仿單標示外用途的接受度日益提高，加上馬匹專用配方的進步，使得更廣泛的治療方法成為可能。遠端醫療平台和行動獸醫護理單位正在擴大農村和偏遠地區的治療涵蓋範圍，人工智慧輔助診斷工具使從業者更容易在早期疾病升級為限制行動能力的問題之前發現並治療它們。

此外，公眾意識的提高和馬主教育的加強，促使人們採取更積極主動、更預防性的馬匹健康方法。飼主正在尋求第二意見，使用穿戴式感測器追蹤運動異常，並希望獸醫在治療效果方面更加透明。這種行為轉變推動了對各種劑型高效、快速起效且易於給藥的治療藥物的需求。同時，藥廠正在投資長效注射劑、偏好口服糊劑和速溶片，以提高服藥順從性和治療效果。在高性能需求、技術創新和馬科動物醫學經濟參與度不斷成長的共同作用下，馬科動物獸醫治療市場在全球範圍內已準備好實現持續、多層次的成長。

部分

藥物（抗發炎、抗感染疾病、抗寄生蟲等）、給藥途徑（口服、注射、局部）、分銷管道（獸醫院分銷管道、獸診所分銷管道、藥房/藥局分銷管道、線上分銷管道、其他分銷管道）

受訪企業範例（共36家）

Addison Biological Laboratory
Animart LLC
Arthrex Inc.
Aurora Pharmaceutical, Inc.
Bayer Animal Health
Bharat Serums and Vaccines Ltd.
Bimeda Inc.
Boehringer Ingelheim
Ceva Sante Animale
Covetrus Inc.
Dechra Pharmaceuticals PLC
Elanco Animal Health
Equine Products UK Ltd.
Esaote SpA
Hallmarq Veterinary Imaging
Heska Corporation
IDEXX Laboratories, Inc.
InGeneron Inc.
Kyoritsu Seiyaku Corporation
Merck Animal Health
Neogen Corporation
Norbrook Laboratories Ltd.
Panav Bio Tech
Vetoquinol SA
Virbac
WF Young, Inc.
Zoetis Inc.

人工智慧整合

我們正在利用可操作的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

The global market for Equine Veterinary Therapeutics estimated at US$1.2 Billion in the year 2024, is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Anti-Inflammatory Drugs, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$844.1 Million by the end of the analysis period. Growth in the Anti-Infective Drugs segment is estimated at 4.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$314.3 Million While China is Forecast to Grow at 10.4% CAGR

The Equine Veterinary Therapeutics market in the U.S. is estimated at US$314.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$350.2 Million by the year 2030 trailing a CAGR of 10.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 6.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Equine Veterinary Therapeutics Market - Key Trends & Drivers Summarized

How Are Advancements in Clinical Interventions Transforming Equine Healthcare?

The field of equine veterinary therapeutics has advanced significantly in recent years, underpinned by innovations in pharmacology, regenerative medicine, and precision diagnostics. Traditional treatment protocols centered on pain management, antiparasitics, and antibiotics are being rapidly supplemented-and in some cases, replaced-by biologic and molecular therapies aimed at addressing chronic conditions at the cellular level. In particular, musculoskeletal disorders such as osteoarthritis, tendonitis, and navicular disease have seen a shift from reliance on corticosteroids and NSAIDs to biologics like platelet-rich plasma (PRP), autologous conditioned serum (ACS), and stem cell therapies that stimulate tissue repair and modulate inflammation more effectively over time.

Respiratory conditions, which are highly prevalent in sport and performance horses, are also receiving focused therapeutic attention. New classes of bronchodilators, mucolytics, and immunomodulators are now being tailored to manage equine asthma and recurrent airway obstruction (RAO) with greater precision and fewer side effects. Additionally, hormonal and metabolic imbalances-particularly equine metabolic syndrome (EMS) and pituitary pars intermedia dysfunction (PPID)-are being treated with advanced formulations that incorporate long-acting agonists, metabolic regulators, and insulin-sensitizing compounds. These developments are enabling more sustained disease management with improved compliance from owners and caretakers.

What Role Are Regenerative and Gene-Based Therapies Playing in Equine Recovery and Performance?

The integration of regenerative medicine into equine therapeutics is altering the trajectory of injury recovery, especially in elite equine athletes where performance longevity is critical. Stem cell therapy, particularly using mesenchymal stem cells (MSCs) derived from bone marrow or adipose tissue, is becoming increasingly routine in the treatment of tendon injuries, cartilage damage, and joint degeneration. These cells possess immunomodulatory properties and tissue-specific regenerative capabilities, significantly reducing re-injury rates in high-performance horses. Veterinary practitioners are also experimenting with exosomes and growth factor-rich extracellular vesicles to enhance cell signaling and accelerate healing at the injury site.

Gene therapy is another emerging frontier, albeit still in the research and trial phase for widespread equine use. Experimental approaches involve the use of viral vectors to deliver anti-inflammatory cytokines or cartilage-protective genes directly into affected joints or tissues. While regulatory and cost barriers persist, the potential for long-acting or even permanent therapeutic effects could redefine chronic care in equine medicine. Adjunct technologies such as shockwave therapy, laser therapy, and pulsed electromagnetic field therapy are also being used in conjunction with regenerative treatments to improve outcomes, reduce healing times, and support rehabilitation programs. The convergence of these biologically advanced therapies with improved diagnostic tools-such as thermal imaging and ultrasonography-is enabling earlier intervention and more precise treatment monitoring.

Where Are Treatment Protocols Evolving to Meet Market-Specific and End-Use Needs?

The global market for equine veterinary therapeutics is not uniform in its demand profile-regional needs, equestrian disciplines, and economic capacity all influence therapeutic development and adoption. In North America and Europe, where racing, showjumping, and dressage dominate the competitive landscape, treatment protocols are heavily aligned with regulatory compliance, anti-doping standards, and proactive wellness strategies. Veterinary hospitals in these regions are well-equipped with diagnostic imaging, endoscopy suites, and surgical units, enabling complex interventions such as arthroscopic surgery, orthopedic fixation, and advanced wound management. In these markets, there is a growing emphasis on prophylactic treatments and longitudinal monitoring of joint health, metabolic status, and immune markers.

Conversely, in emerging equine markets such as Brazil, India, and the Middle East, demand is more focused on cost-effective therapeutics that can be deployed in field settings. Common conditions such as colic, parasitic infestations, and wound infections drive demand for oral anthelmintics, antimicrobial powders, and electrolyte therapies. However, rising income levels and increased participation in international competitions are also spurring interest in performance-enhancing therapeutics, injectable joint supplements, and pre-race conditioning agents. Additionally, therapeutic approaches are evolving to meet the demands of non-competitive segments, such as therapy horses and recreational equines, where behavioral wellness and chronic pain management are critical concerns. Behavioral therapeutics-especially anxiolytics and natural calming agents-are gaining traction in facilities that use horses for equine-assisted therapy or rehabilitation.

What Forces Are Driving Growth in the Global Equine Veterinary Therapeutics Market?

The growth in the equine veterinary therapeutics market is driven by several factors that reflect the increasing medicalization of horse care, the professionalization of equestrian sports, and the rising expectations of owners and trainers regarding equine health outcomes. One of the most prominent growth drivers is the expanded use of horses across diverse sectors-including competitive sports, therapy, leisure, and ceremonial use-all of which demand tailored, high-quality therapeutic interventions. The economic value of performance horses, often running into hundreds of thousands or even millions of dollars, justifies the investment in advanced diagnostics, preventive care, and novel therapeutics that can extend performance longevity and reduce the likelihood of catastrophic injuries.

Another powerful growth catalyst is the strengthening regulatory and clinical infrastructure that supports evidence-based veterinary practice. Veterinary associations, pharmaceutical firms, and equestrian regulatory bodies are working collaboratively to standardize treatment protocols, improve drug approval pathways, and encourage innovation in therapeutic development. The growing acceptance of off-label use of human pharmaceuticals in veterinary contexts-paired with advances in equine-specific formulations-is enabling access to a broader therapeutic arsenal. Telemedicine platforms and mobile veterinary units are expanding therapeutic access to rural and remote regions, while AI-assisted diagnostic tools are making it easier for practitioners to identify and treat early-stage conditions before they escalate into performance-limiting issues.

Moreover, increased public awareness and owner education are contributing to more proactive and preventive approaches to equine health. Owners are seeking second opinions, using wearable sensors to track movement abnormalities, and demanding more transparency from veterinarians regarding treatment efficacy. These behavioral shifts are driving demand for high-efficacy, quick-onset, and easily administered therapeutics across all dosage forms. Simultaneously, pharmaceutical companies are investing in long-acting injectables, palatable oral pastes, and rapid-dissolve tablets to improve dosing compliance and treatment outcomes. With the convergence of high-performance demand, technological innovation, and growing economic participation in equine care, the equine veterinary therapeutics market is well-positioned for sustained, multi-tiered growth globally.

SCOPE OF STUDY:

The report analyzes the Equine Veterinary Therapeutics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Drugs (Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs, Other Drugs); Administration Route (Oral, Parenteral, Topical); Distribution Channel (Veterinary Hospital Distribution Channel, Veterinary Clinics Distribution Channel, Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

Addison Biological Laboratory
Animart LLC
Arthrex Inc.
Aurora Pharmaceutical, Inc.
Bayer Animal Health
Bharat Serums and Vaccines Ltd.
Bimeda Inc.
Boehringer Ingelheim
Ceva Sante Animale
Covetrus Inc.
Dechra Pharmaceuticals PLC
Elanco Animal Health
Equine Products UK Ltd.
Esaote S.p.A.
Hallmarq Veterinary Imaging
Heska Corporation
IDEXX Laboratories, Inc.
InGeneron Inc.
Kyoritsu Seiyaku Corporation
Merck Animal Health
Neogen Corporation
Norbrook Laboratories Ltd.
Panav Bio Tech
Vetoquinol S.A.
Virbac
W.F. Young, Inc.
Zoetis Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Tariff Impact on Global Supply Chain Patterns
- Equine Veterinary Therapeutics - Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Rising Prevalence of Equine Musculoskeletal and Respiratory Disorders Drives Therapeutic Product Demand
- Expansion of Equine Sports and Breeding Industries Throws Spotlight on Performance-Enhancing Treatments
- Development of Targeted Biologics and Regenerative Therapies Strengthens Business Case for Precision Veterinary Care
- Growth in Geriatric Equine Population Spurs Use of Anti-Inflammatory and Pain Management Solutions
- Increased Regulatory Approvals for Equine-Specific Pharmaceuticals Expand Therapeutic Options
- Collaboration With Academic Equine Centers Enhances R&D and Clinical Validation Pipelines
- Surge in Equine Surgery and Rehabilitation Clinics Propels Use of Post-Operative Therapeutic Protocols
- Rising Adoption of Long-Acting Injectable Formulations Improves Treatment Compliance
- Integration of Advanced Imaging and Diagnostic Tools Supports Evidence-Based Therapy Planning
- Innovation in Transdermal and Oral Delivery Methods Enhances Treatment Efficacy and Convenience
- Shift Toward Immunomodulators and Autoimmune Disease Management Fuels Development of Specialized Therapies
- Growth in Equestrian Insurance Coverage Expands Access to Advanced and Costlier Treatments
- Demand for Complementary Therapies Such as Acupuncture and Chiropractic Drives Holistic Treatment Protocols
- Development of Combination Therapies Supports Complex Multi-Symptom Management
- Global Expansion of Equine Referral Hospitals and Veterinary Networks Strengthens Distribution Reach
- Efforts to Reduce Antibiotic Overuse Encourage Development of Novel Antimicrobial Agents
- Seasonal Variation in Parasite and Infectious Disease Incidence Drives Demand for Preventive Therapeutics
- Increased Awareness of Equine Mental and Behavioral Health Spurs Demand for Anxiolytics and Mood Modulators
- Initiatives in Owner Education and Compliance Tools Enhance Long-Term Therapeutic Success
- Rising Export of High-Value Horses Encourages Use of Travel-Readiness Medications and Immune Boosters
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Equine Veterinary Therapeutics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 3: World Historic Review for Equine Veterinary Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 4: World 16-Year Perspective for Equine Veterinary Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Anti-Inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 6: World Historic Review for Anti-Inflammatory Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 7: World 16-Year Perspective for Anti-Inflammatory Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Anti-Infective Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 9: World Historic Review for Anti-Infective Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 10: World 16-Year Perspective for Anti-Infective Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Parasiticides Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 12: World Historic Review for Parasiticides Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 13: World 16-Year Perspective for Parasiticides Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Other Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 15: World Historic Review for Other Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 16: World 16-Year Perspective for Other Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Pharmacies & Drug Stores Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 18: World Historic Review for Pharmacies & Drug Stores Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 19: World 16-Year Perspective for Pharmacies & Drug Stores Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 21: World Historic Review for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 22: World 16-Year Perspective for Online Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 24: World Historic Review for Other Distribution Channels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 25: World 16-Year Perspective for Other Distribution Channels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Veterinary Hospital Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 27: World Historic Review for Veterinary Hospital Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 28: World 16-Year Perspective for Veterinary Hospital Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 29: World Recent Past, Current & Future Analysis for Veterinary Clinics Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 30: World Historic Review for Veterinary Clinics Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 31: World 16-Year Perspective for Veterinary Clinics Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 32: World Recent Past, Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 33: World Historic Review for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 34: World 16-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 35: World Recent Past, Current & Future Analysis for Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 36: World Historic Review for Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 37: World 16-Year Perspective for Parenteral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 38: World Recent Past, Current & Future Analysis for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 39: World Historic Review for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 40: World 16-Year Perspective for Topical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES
- Equine Veterinary Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 41: USA Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 42: USA Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 43: USA 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 44: USA Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 45: USA Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 46: USA 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 47: USA Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 48: USA Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 49: USA 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
CANADA
- TABLE 50: Canada Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 51: Canada Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 52: Canada 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 53: Canada Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 54: Canada Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 55: Canada 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 56: Canada Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 57: Canada Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 58: Canada 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
JAPAN
- Equine Veterinary Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 59: Japan Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 60: Japan Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 61: Japan 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 62: Japan Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 63: Japan Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 64: Japan 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 65: Japan Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 66: Japan Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 67: Japan 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
CHINA
- Equine Veterinary Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 68: China Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 69: China Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 70: China 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 71: China Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 72: China Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 73: China 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 74: China Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 75: China Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 76: China 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
EUROPE
- Equine Veterinary Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 77: Europe Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 78: Europe Historic Review for Equine Veterinary Therapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 79: Europe 16-Year Perspective for Equine Veterinary Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
- TABLE 80: Europe Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 81: Europe Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 82: Europe 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 83: Europe Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 84: Europe Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 85: Europe 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 86: Europe Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 87: Europe Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 88: Europe 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
FRANCE
- Equine Veterinary Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 89: France Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 90: France Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 91: France 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 92: France Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 93: France Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 94: France 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 95: France Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 96: France Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 97: France 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
GERMANY
- Equine Veterinary Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 98: Germany Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 99: Germany Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 100: Germany 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 101: Germany Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 102: Germany Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 103: Germany 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 104: Germany Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 105: Germany Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 106: Germany 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
ITALY
- TABLE 107: Italy Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 108: Italy Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 109: Italy 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 110: Italy Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 111: Italy Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 112: Italy 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 113: Italy Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 114: Italy Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 115: Italy 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
UNITED KINGDOM
- Equine Veterinary Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 116: UK Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 117: UK Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 118: UK 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 119: UK Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 120: UK Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 121: UK 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 122: UK Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 123: UK Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 124: UK 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
SPAIN
- TABLE 125: Spain Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 126: Spain Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 127: Spain 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 128: Spain Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 129: Spain Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 130: Spain 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 131: Spain Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 132: Spain Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 133: Spain 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
RUSSIA
- TABLE 134: Russia Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 135: Russia Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 136: Russia 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 137: Russia Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 138: Russia Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 139: Russia 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 140: Russia Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 141: Russia Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 142: Russia 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
REST OF EUROPE
- TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 144: Rest of Europe Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 145: Rest of Europe 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 147: Rest of Europe Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 148: Rest of Europe 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 150: Rest of Europe Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 151: Rest of Europe 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
ASIA-PACIFIC
- Equine Veterinary Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 153: Asia-Pacific Historic Review for Equine Veterinary Therapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 154: Asia-Pacific 16-Year Perspective for Equine Veterinary Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
- TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 156: Asia-Pacific Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 157: Asia-Pacific 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 159: Asia-Pacific Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 160: Asia-Pacific 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 162: Asia-Pacific Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 163: Asia-Pacific 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
AUSTRALIA
- Equine Veterinary Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
- TABLE 164: Australia Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 165: Australia Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 166: Australia 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 167: Australia Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 168: Australia Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 169: Australia 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 170: Australia Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 171: Australia Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 172: Australia 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
INDIA
- Equine Veterinary Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
- TABLE 173: India Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 174: India Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 175: India 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 176: India Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 177: India Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 178: India 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 179: India Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 180: India Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 181: India 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
SOUTH KOREA
- TABLE 182: South Korea Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 183: South Korea Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 184: South Korea 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 185: South Korea Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 186: South Korea Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 187: South Korea 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 188: South Korea Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 189: South Korea Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 190: South Korea 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
REST OF ASIA-PACIFIC
- TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 192: Rest of Asia-Pacific Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 195: Rest of Asia-Pacific Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 198: Rest of Asia-Pacific Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
LATIN AMERICA
- Equine Veterinary Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
- TABLE 200: Latin America Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 201: Latin America Historic Review for Equine Veterinary Therapeutics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 202: Latin America 16-Year Perspective for Equine Veterinary Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
- TABLE 203: Latin America Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 204: Latin America Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 205: Latin America 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 206: Latin America Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 207: Latin America Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 208: Latin America 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 209: Latin America Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 210: Latin America Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 211: Latin America 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
ARGENTINA
- TABLE 212: Argentina Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 213: Argentina Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 214: Argentina 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 215: Argentina Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 216: Argentina Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 217: Argentina 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 218: Argentina Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 219: Argentina Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 220: Argentina 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
BRAZIL
- TABLE 221: Brazil Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 222: Brazil Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 223: Brazil 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 224: Brazil Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 225: Brazil Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 226: Brazil 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 227: Brazil Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 228: Brazil Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 229: Brazil 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
MEXICO
- TABLE 230: Mexico Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 231: Mexico Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 232: Mexico 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 233: Mexico Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 234: Mexico Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 235: Mexico 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 236: Mexico Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 237: Mexico Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 238: Mexico 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
REST OF LATIN AMERICA
- TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 240: Rest of Latin America Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 241: Rest of Latin America 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 243: Rest of Latin America Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 244: Rest of Latin America 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 246: Rest of Latin America Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 247: Rest of Latin America 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
MIDDLE EAST
- Equine Veterinary Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
- TABLE 248: Middle East Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 249: Middle East Historic Review for Equine Veterinary Therapeutics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 250: Middle East 16-Year Perspective for Equine Veterinary Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
- TABLE 251: Middle East Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 252: Middle East Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 253: Middle East 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 254: Middle East Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 255: Middle East Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 256: Middle East 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 257: Middle East Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 258: Middle East Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 259: Middle East 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
IRAN
- TABLE 260: Iran Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 261: Iran Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 262: Iran 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 263: Iran Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 264: Iran Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 265: Iran 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 266: Iran Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 267: Iran Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 268: Iran 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
ISRAEL
- TABLE 269: Israel Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 270: Israel Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 271: Israel 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 272: Israel Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 273: Israel Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 274: Israel 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 275: Israel Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 276: Israel Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 277: Israel 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
SAUDI ARABIA
- TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 279: Saudi Arabia Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 280: Saudi Arabia 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 282: Saudi Arabia Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 283: Saudi Arabia 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 285: Saudi Arabia Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 286: Saudi Arabia 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
UNITED ARAB EMIRATES
- TABLE 287: UAE Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 288: UAE Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 289: UAE 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 290: UAE Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 291: UAE Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 292: UAE 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 293: UAE Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 294: UAE Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 295: UAE 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
REST OF MIDDLE EAST
- TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 297: Rest of Middle East Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 298: Rest of Middle East 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 300: Rest of Middle East Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 301: Rest of Middle East 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 303: Rest of Middle East Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 304: Rest of Middle East 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030
AFRICA
- Equine Veterinary Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
- TABLE 305: Africa Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 306: Africa Historic Review for Equine Veterinary Therapeutics by Drugs - Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 307: Africa 16-Year Perspective for Equine Veterinary Therapeutics by Drugs - Percentage Breakdown of Value Sales for Anti-Inflammatory Drugs, Anti-Infective Drugs, Parasiticides Drugs and Other Drugs for the Years 2014, 2025 & 2030
- TABLE 308: Africa Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 309: Africa Historic Review for Equine Veterinary Therapeutics by Distribution Channel - Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 310: Africa 16-Year Perspective for Equine Veterinary Therapeutics by Distribution Channel - Percentage Breakdown of Value Sales for Pharmacies & Drug Stores Distribution Channel, Online Distribution Channel, Other Distribution Channels, Veterinary Hospital Distribution Channel and Veterinary Clinics Distribution Channel for the Years 2014, 2025 & 2030
- TABLE 311: Africa Recent Past, Current & Future Analysis for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 312: Africa Historic Review for Equine Veterinary Therapeutics by Administration Route - Oral, Parenteral and Topical Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
- TABLE 313: Africa 16-Year Perspective for Equine Veterinary Therapeutics by Administration Route - Percentage Breakdown of Value Sales for Oral, Parenteral and Topical for the Years 2014, 2025 & 2030